November 17, 2021 07:14 AM ESTUpdated 08:14 AM

Covid-19 roundup: CDC advisory committee to discuss Pfizer/BioNTech boosters for all adults; US buys up $1B in GSK/Vir mAbs

Nicole DeFeudis

Editor

Zachary Brennan

Senior Editor

About a week after Pfizer asked regulators to expand its Covid-19 booster shot EUA to include all adults, the CDC’s Advisory Committee on Immunization Practices …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: CDC advisory committee to discuss Pfizer/BioNTech boosters for all adults; US buys up $1B in GSK/Vir mAbs

Nicole DeFeudis

Editor

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

Critical Junctures in Gene Therapy Clinical Material Manufacturing: Where Do I Start? And Will It Work?

Covid-19 roundup: CDC ad­vi­so­ry com­mit­tee to dis­cuss Pfiz­er/BioN­Tech boost­ers for all adults; US buys up $1B in GSK/Vir mAbs

Editor

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: CDC advisory committee to discuss Pfizer/BioNTech boosters for all adults; US buys up $1B in GSK/Vir mAbs